Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

Partners in Learning - a PCR/CRF Collaboration

Anchorperson: M. Leon

Spokesperson: F. Praz

Summary

This session examines the integrated role of heart failure therapies in the peri- and post-procedural management of patients undergoing surgical and transcatheter valve interventions. It reviews current and emerging clinical trial data, discusses identifying high-risk patients, and explores advanced modalities such as cardiac resynchronization and circulatory support to improve clinical outcomes when medical therapy alone is insufficient.

Learning Objectives

To appreciate the synergistic role of heart failure therapies before and after surgical and transcatheter valve interventions
To learn more about recent and upcoming clinical trials that underpin current and future treatment strategies
To understand how to identify patients at high risk of peri- and post-procedural heart failure and instigate measures that will ensure best clinical outcomes

Presentations available when logged in:

Welcome and session objectives
Optimal medical therapy before and after valve intervention: what are we really talking about?
Designing the future: what do we need from the next wave of clinical trials?
Cardiac resynchronisation and circulatory support: what do we do when medical therapy fails?

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

Partners in Learning - a PCR/CRF Collaboration

Learning Objectives

Log in or create account for free